89 related articles for article (PubMed ID: 1849040)
1. Role of the prostaglandin E2 receptor in mammary tumor metastasis.
Fulton AM; Zhang SZ; Chong YC
Cancer Res; 1991 Apr; 51(8):2047-50. PubMed ID: 1849040
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 receptor heterogeneity and dysfunction in mammary tumor cells.
Fulton AM; Laterra JJ; Hanchin CM
J Cell Physiol; 1989 Apr; 139(1):93-9. PubMed ID: 2540214
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 receptor modulation affects tumor cell adhesion to laminin.
Zhang SZ; Fulton AM
J Cell Physiol; 1991 Nov; 149(2):208-13. PubMed ID: 1684184
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 receptor activity and susceptibility to natural killer cells.
Fulton AM; Chong YC
J Leukoc Biol; 1992 Feb; 51(2):176-80. PubMed ID: 1331278
[TBL] [Abstract][Full Text] [Related]
5. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
6. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
Mahan M; Meunier J; Newby M; Young MR
J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.
Español A; Eiján AM; Mazzoni E; Davel L; Jasnis MA; Sacerdote De Lustig E; Sales ME
Int J Mol Med; 2002 Jun; 9(6):651-7. PubMed ID: 12011984
[TBL] [Abstract][Full Text] [Related]
11. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
[TBL] [Abstract][Full Text] [Related]
12. Interactions of natural effector cells and prostaglandins in the control of metastasis.
Fulton AM
J Natl Cancer Inst; 1987 Apr; 78(4):735-41. PubMed ID: 3470548
[TBL] [Abstract][Full Text] [Related]
13. Growth stimulation by PGE2 and EGF activates cyclic AMP-dependent and -independent pathways in primary cultures of mouse mammary epithelial cells.
Imagawa W; Bandyopadhyay GK; Wallace D; Nandi S
J Cell Physiol; 1988 Jun; 135(3):509-15. PubMed ID: 2456289
[TBL] [Abstract][Full Text] [Related]
14. Loss of prostaglandin E receptors during progression of rat mammary tumors from hormonal dependence to autonomy.
Abou-Issa H; Minton JP
J Natl Cancer Inst; 1986 Jan; 76(1):101-6. PubMed ID: 2867240
[TBL] [Abstract][Full Text] [Related]
15. Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes.
Brown DM; Phipps RP
Cell Immunol; 1995 Mar; 161(1):79-87. PubMed ID: 7867087
[TBL] [Abstract][Full Text] [Related]
16. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas.
Fulton AM; Heppner GH
Cancer Res; 1985 Oct; 45(10):4779-84. PubMed ID: 4027966
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
18. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
19. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of prostaglandin E2 binding in murine mammary tumor cells differing in metastatic potential.
Fulton AM; Hanchin CM; Butler WB
Invasion Metastasis; 1988; 8(1):17-30. PubMed ID: 3422634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
